Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia ‘diagnosis of exclusion’ : Blood Coagulation & Fibrinolysis

Journal Logo

Advanced Search
LETTERS TO THE EDITOR

Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia ‘diagnosis of exclusion’

Langabeer, Stephen E.

Author Information

Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland

Correspondence to Stephen E. Langabeer, PhD, FRCPath, Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin D08 W9RT, Ireland Tel: +353 1 4162413; e-mail: [email protected]

Received 20 September, 2022

Accepted 23 September, 2022

Blood Coagulation & Fibrinolysis 33(8):p 475-476, December 2022. | DOI: 10.1097/MBC.0000000000001173
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid